Multivariate models | Pain severity | |||
---|---|---|---|---|
Pain Now | Pain Strongest | Pain Average | ||
(0–10) | (0–10) | (0–10) | ||
β | Β | β | ||
Markers of Inflammation | DAS28-CRP (0-9.4) | 0.53*** | 0.36*** | 0.31** |
US-Combined (0–48) | 0.01 | 0.12 | 0.16 | |
Adjusted R2 | 0.27*** | 0.14*** | 0.12** | |
Markers of Inflammation and Pain Sensitivity | DAS28-CRP (0-9.4) | 0.53*** | 0.32** | 0.29** |
US-Combined (0–48) | 0.02 | 0.13 | 0.18 | |
TS (0–10) | 0.18* | 0.17 | -0.01 | |
CPM (kPa) | -0.02 | -0.18 | -0.20* | |
Adjusted R2 | 0.30*** | 0.20*** | 0.15** | |
Discrete Markers of Inflammation and Pain Sensitivity | CRP (mg/l) †| 0.36** | 0.42*** | 0.32* |
SJC (0–28) †| 0.28** | 0.14 | 0.10 | |
US-SH (0–48) †| 0.12 | 0.20 | 0.22 | |
US-PD (0–48) †| -0.08 | -0.06 | -0.02 | |
TS (0–10) | 0.20* | 0.16 | -0.01 | |
CPM (kPa) | 0.09 | -0.06 | -0.12 | |
Adjusted R2 | 0.19** | 0.24*** | 0.16** | |
Markers of Disease Activity, Pain Sensitivity, and Anthropometric Variables | DAS28-CRP (mg/l) | 0.53*** | 0.32** | 0.32** |
US-Combined (0–48) | 0.01 | 0.09 | 0.22* | |
TS (0–10) | 0.19* | 0.25* | -0.02 | |
CPM (kPa) | -0.02 | -0.19 | -0.18 | |
Age (y) | 0.03 | 0.06 | 0.17 | |
Sex (f) | 0.04 | 0.16 | 0.10 | |
BMI (kg/m2) | -0.01 | -0.01 | -0.01 | |
Adjusted R2 | 0.28*** | 0.22*** | 0.17** |